Event chart NEOGENOMICS, INC. |
|
|
Upcoming events on NEOGENOMICS, INC. |
|
11/01/22 | | Q3 2022 Earnings Release (Projected) |
02/22/23 | | FY 2022 Earnings Release (Projected) |
05/02/23 | | Q1 2023 Earnings Release (Projected) |
08/01/23 | | Interim 2023 Earnings Release (Projected) |
|
Past events on NEOGENOMICS, INC. |
|
08/09/22 | 08:30am | | Interim 2022 Earnings Call |
08/09/22 | 07:00am | | Interim 2022 Earnings Release |
06/13/22 | | Goldman Sachs Global Healthcare Conference |
06/08/22 | 12:20pm | | William Blair Growth Stock Conference |
06/06/22 | 02:15pm | | American society of clinical oncology meeting - abstract no: 9579 |
06/06/22 | 02:15pm | | American society of clinical oncology meeting - abstract no: 6052 |
06/06/22 | 02:15pm | | American society of clinical oncology meeting - abstract no: 6017 |
06/05/22 | 09:00am | | American society of clinical oncology meeting - abstract no: 3039 |
06/04/22 | 09:00am | | American Society of Clinical Oncology Meeting |
06/02/22 | 10:00am | | Annual General Meeting |
|
Past dividends on NEOGENOMICS, INC. |
|
- No events available -
|
|
Fiscal Period : December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
Sales M $ |
Released Forecast Spread | 259 257 0,58% | 277 272 1,9% | 409 406 0,66% | 444 443 0,44% | 484 485 -0,06% | 491 |
Operating income (EBITDA) M $ |
Released Forecast Spread | 32,8 31,7 3,3% | 43,6 39,9 9,1% | 57,2 57,5 -0,45% | 34,8 33,1 5,3% | -4,16 -2,03 -105% | -69,3 |
Operating profit (EBIT) M $ |
Released Forecast Spread | 3,38 0,50 575% | 10,0 9,77 2,7% | 13,0 14,8 -12% | -14,0 -11,3 -24% | -119 -101 -17% | -156 |
Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | -3,48 -6,44 46% | 3,82 3,10 23% | 3,65 3,82 -4,5% | -14,1 -18,3 23% | -15,1 -3,98 -279% | -179 |
Net income M $ |
Released Forecast Spread | -11,4 -16,5 31% | 6,09 5,57 9,3% | 8,01 3,52 127% | 4,17 -8,48 149% | -8,35 0,68 -1 326% | -166 |
EPS $ |
Released Forecast Spread | -0,14 -0,21 33% | 0,07 0,06 8,9% | 0,08 0,04 122% | 0,04 -0,08 151% | -0,07 0,00 -4 092% | -1,33 | Announcement Date | 02/21/2018 | 02/19/2019 | 02/27/2020 | 02/24/2021 | 02/23/2022 | - |
|
|
Fiscal Period : December | 2020 Q2 | 2020 Q3 | 2020 Q4 | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 |
Sales M $ |
Released Forecast Spread | 87,0 87,1 -0,10% | 125 126 -0,53% | 126 123 2,1% | 116 112 3,0% | 122 118 3,2% | 121 125 -3,0% | 126 126 -0,03% | 117 116 0,62% | 125 123 1,5% | 123 | 126 | 129 | 137 | 137 |
Operating income (EBITDA) M $ |
Released Forecast Spread | -7,22 -5,97 -21% | 16,7 13,9 21% | 18,3 15,7 16% | 4,19 9,45 -56% | 4,55 0,74 511% | -3,11 -0,09 -3 254% | -9,79 -6,72 -46% | -19,0 -20,0 4,8% | -16,3 -18,8 13% | -18,8 | -16,5 | -14,6 | -11,7 | -7,29 |
Operating profit (EBIT) M $ |
Released Forecast Spread | -18,9 -16,7 -14% | 4,67 1,51 210% | 5,54 4,71 18% | -15,1 -2,74 -450% | -22,4 -10,7 -109% | -39,7 -18,5 -115% | -41,6 -29,3 -42% | -52,0 -40,8 -27% | -39,7 -41,5 4,2% | -39,1 | -37,7 | -41,1 | -34,0 | -31,8 |
Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | -18,0 -16,8 -6,9% | 2,22 3,31 -33% | 7,57 3,02 151% | -21,1 -5,40 -292% | 73,4 -12,6 683% | -23,2 -21,4 -8,5% | -44,2 -33,4 -32% | -53,2 -43,2 -23% | -41,0 -45,1 9,0% | -44,2 | -42,5 | -43,1 | -35,7 | -33,9 |
Net income M $ |
Released Forecast Spread | -6,82 -15,4 56% | 2,56 2,70 -5,3% | 15,4 2,48 522% | -22,1 -6,27 -253% | 75,9 -12,5 707% | -20,3 -20,4 0,43% | -41,8 -33,3 -26% | -49,4 -42,8 -15% | -35,3 -42,1 16% | -41,6 | -39,4 | -41,1 | -33,9 | -32,1 |
EPS $ |
Released Forecast Spread | -0,06 -0,14 57% | 0,04 0,03 54% | 0,13 0,02 643% | -0,19 -0,05 -262% | 0,59 -0,10 666% | -0,17 -0,16 -4,4% | -0,34 -0,27 -25% | -0,40 -0,35 -16% | -0,28 -0,34 17% | -0,33 | -0,32 | -0,33 | -0,28 | -0,26 | Announcement Date | 07/28/2020 | 10/27/2020 | 02/24/2021 | 05/05/2021 | 08/06/2021 | 11/04/2021 | 02/23/2022 | 04/27/2022 | 08/09/2022 | - | - | - | - | - | |
|
|
Upcoming sector events for NEOGENOMICS, INC. |
|
|
|
Past sector events for NEOGENOMICS, INC. |
|
|
|
|
|
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|